Skip to main content
. Author manuscript; available in PMC: 2020 Nov 12.
Published in final edited form as: J Alzheimers Dis. 2020;75(4):1241–1252. doi: 10.3233/JAD-200232

Table 2.

Relation of diabetes status categories (normal glucose tolerance [NGT; reference category], pre-diabetes, type 2 diabetes [T2D]), and of glycemia ascertained as hemoglobin A1c (HbA1c), with global brain amyloid level categories (low, intermediate, and high). Odds ratios (OR) were estimated with multinomial logistic regression. OR report the odds of the designated amyloid group compared to low amyloid/Model 1 is unadjusted; Model 2 is adjusted for age, sex, and APOE-ε4; Model 3 is adjusted for lipids, body mass index, and differences in medication.

Model 1 Model 2 Model 3
No. Amyloid Group OR (95% CI) p value OR (95% CI) p value OR (95% CI) P value
Type 2 diabetes categories
NGT 58 Intermediate 1.0 1.0 1.0
12 High 1.0 1.0 1.0
Pre-diabetes 53 Intermediate 1.70 (0.99, 2.94) 0.056 1.92 (1.06, 3.47) 0.031 1.68 (0.91, 3.11) 0.098
10 High 1.55 (0.61, 3.94) 0.35 1.81 (0.67, 4.91) 0.25 1.58 (0.56, 4.44) 0.38
T2D 50 Intermediate 1.08 (0.64, 1.82) 0.77 1.15 (0.65, 2.03) 0.63 1.21 (0.50, 2.95) 0.67
6 High 0.63 (0.22, 1.78) 0.38 0.53 (0.18, 1.62) 0.27 0.90 (0.20, 4.03) 0.89
p (global) 0.24 0.11 0.55
Hemoglobin A1c (HbA1c)
HbA1c 161 Intermediate 0.96 (0.82, 1.13) 0.63 1.00 (0.84, 1.19) 0.99 1.02 (0.81, 1.28) 0.89
28 High 0.57 (0.32, 1.01) 0.054 0.5 (0.31, 1.03) 0.062 0.59 (0.28, 1.26) 0.18
p (global) 0.15 0.17 0.37

CI = Confidence interval